Original Resolution: 160x200 Pharmacoeconomic Review Report Tocilizumab Actemra Ncbi Bookshelf Tocilizumab (inn, trade name actemra), also known as atlizumab, is an immunosuppressive drug, mainly for the treatment of rheumatoid arthritis (ra) and systemic juvenile idiopathic arthritis.